Vimarsana
Biggest News Aggregation in the World

Page 5 - Nasdaq Bdtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bdtx Today - Breaking & Trending Today

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Expected to Post Q1 2022 Earnings of ($0.77) Per Share - Vimarsana News

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Expected to Post Q1 2022 Earnings of ($0.77) Per Share

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) – Equities researchers at Wedbush issued their Q1 2022 EPS estimates for shares of Black Diamond Therapeutics in a research report issued on Tuesday, March 29th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of ($0.77) for the quarter. Wedbush currently has […]

Wedbush Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral - Vimarsana News

Wedbush Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) was downgraded by equities researchers at Wedbush from an “outperform” rating to a “neutral” rating in a report issued on Tuesday, Briefing.com reports. A number of other analysts also recently weighed in on the stock. Stifel Nicolaus reduced their target price on shares of Black Diamond Therapeutics from […]

HC Wainwright Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral - Vimarsana News

HC Wainwright Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) was downgraded by HC Wainwright from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat.com reports. Separately, Stifel Nicolaus lowered their price target on shares of Black Diamond Therapeutics from $10.00 to $4.00 and set a “hold” rating for the company in […]

Black Diamond Therapeutics (NASDAQ:BDTX) Releases Earnings Results, Beats Expectations By $0.29 EPS - Vimarsana News

Black Diamond Therapeutics (NASDAQ:BDTX) Releases Earnings Results, Beats Expectations By $0.29 EPS

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) posted its earnings results on Thursday. The company reported ($0.71) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($1.00) by $0.29, MarketWatch Earnings reports. Shares of NASDAQ BDTX traded up $0.04 during mid-day trading on Friday, reaching $3.06. The company had a trading volume […]

Geode Capital Management LLC Reduces Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Vimarsana News

Geode Capital Management LLC Reduces Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Geode Capital Management LLC lowered its stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) by 2.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 349,980 shares of the company’s stock after selling 9,622 shares during the […]